Euntaek Yoon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Euntaek Yoon has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Jung-In Kim
Department of Radiation Oncology Seoul National University Hospital Seoul Republic of Korea
11 shared publications - Chang Heon Choi
Department of Radiation Oncology Seoul National University Hospital Seoul Republic of Korea
10 shared publications - Inbum Lee
Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea
9 shared publications - Bo-Wi Cheon
Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea
8 shared publications - Jong Min Park
Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea
8 shared publications - Yoonsuk Huh
Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea
8 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 27 (12)
Evaluation of a multifunctional phantom for geometric, image quality, and dosimetric constancy of megavoltage electronic portal imaging devices
Background: Routine quality assurance (QA) of linear accelerators and electronic portal imaging devices (EPIDs) often requires separate devices and acquisition procedures for geometric, image‐quality, radiation‐field, multileaf collimator (MLC), and dosimetric checks. A multifunctional phantom could consolidate these assessments within a single QA workflow. Purpose: To evaluate the week‐to‐week reproducibility of measurements obtained with MZ Slab, a multifunctional megavoltage EPID phantom, on three linear accelerators with different EPID configurations. Methods: Measurements were performed weekly for four weeks on TrueBeam STx, Halcyon, and Harmony Pro. Each session comprised three acquisition sets with phantom removal and repositioning between sets. The phantom provided measurements of geometric accuracy, image quality, material‐response isotropy, and radiation‐field size, together with qualitative MLC light‐field checks. Weekly values were summarized as mean and within‐session standard deviation, and changes were assessed relative to week 1. Field sizes were compared with open‐field EPID images and IC Profiler measurements. Dose‐calibrated portal images acquired on TrueBeam were compared with the week 1 image using mean response change and gamma passing rates. Results: Central‐marker offset ranged from 0.24 to 0.78 mm across units, with a maximum change from week 1 of 0.29 mm. Marker‐distance deviations changed by no more than 0.03 mm. The maximum changes in mean relative contrast transfer function and low‐contrast contrast‐to‐noise ratio were 0.011 (2.6%) and 1.81 (5.0%), respectively, relative to the week 1 baseline. Uniformity deviation and normalized noise changed by up to 0.50 and 0.17 percentage points, and material‐specific normalized response by up to 0.014. Field sizes changed by up to 0.56 mm and agreed with open‐field EPID measurements within 0.3 mm. IC Profiler values were 0.2–0.9 mm larger than MZ Slab values. MLC leaf ends remained within the printed ± 1 mm tolerance. At week 4, mean portal‐image response had increased by 0.77%, with a gamma passing rate of 99.65% at 1%/1 mm. Conclusions: MZ Slab supported geometric, image‐quality, radiation‐field, qualitative MLC, and portal‐dosimetry assessments within a single‐phantom QA workflow. Measurements on three linacs characterized within‐session reproducibility and week‐to‐week consistency over four weeks. Longer observation and deliberate perturbation testing are required to establish action limits and fault‐detection sensitivity.
- 17 November 2026
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 27 (12)
Open AccessEvaluation of a multifunctional phantom for geometric, image quality, and dosimetric constancy of megavoltage electronic portal imaging devices
Background: Routine quality assurance (QA) of linear accelerators and electronic portal imaging devices (EPIDs) often requires separate devices and acquisition procedures for geometric, image‐quality, radiation‐field, multileaf collimator (MLC), and dosimetric checks. A multifunctional phantom could consolidate these assessments within a single QA workflow. Purpose: To evaluate the week‐to‐week reproducibility of measurements obtained with MZ Slab, a multifunctional megavoltage EPID phantom, on three linear accelerators with different EPID configurations. Methods: Measurements were performed weekly for four weeks on TrueBeam STx, Halcyon, and Harmony Pro. Each session comprised three acquisition sets with phantom removal and repositioning between sets. The phantom provided measurements of geometric accuracy, image quality, material‐response isotropy, and radiation‐field size, together with qualitative MLC light‐field checks. Weekly values were summarized as mean and within‐session standard deviation, and changes were assessed relative to week 1. Field sizes were compared with open‐field EPID images and IC Profiler measurements. Dose‐calibrated portal images acquired on TrueBeam were compared with the week 1 image using mean response change and gamma passing rates. Results: Central‐marker offset ranged from 0.24 to 0.78 mm across units, with a maximum change from week 1 of 0.29 mm. Marker‐distance deviations changed by no more than 0.03 mm. The maximum changes in mean relative contrast transfer function and low‐contrast contrast‐to‐noise ratio were 0.011 (2.6%) and 1.81 (5.0%), respectively, relative to the week 1 baseline. Uniformity deviation and normalized noise changed by up to 0.50 and 0.17 percentage points, and material‐specific normalized response by up to 0.014. Field sizes changed by up to 0.56 mm and agreed with open‐field EPID measurements within 0.3 mm. IC Profiler values were 0.2–0.9 mm larger than MZ Slab values. MLC leaf ends remained within the printed ± 1 mm tolerance. At week 4, mean portal‐image response had increased by 0.77%, with a gamma passing rate of 99.65% at 1%/1 mm. Conclusions: MZ Slab supported geometric, image‐quality, radiation‐field, qualitative MLC, and portal‐dosimetry assessments within a single‐phantom QA workflow. Measurements on three linacs characterized within‐session reproducibility and week‐to‐week consistency over four weeks. Longer observation and deliberate perturbation testing are required to establish action limits and fault‐detection sensitivity.
- Open Access
- 30 September 2026
- Published by Korean Society of Medical Physics in Progress in Medical Physics
- Vol. 37 (3) , 89-107
Risk-Based Management of Patients with Cardiac Implantable Electronic Devices Underwent Radiation Therapy: A Practical Review
Na Hye Kwon, Inbum Lee, Euntaek Yoon, Bo-Wi Cheon, Young Jae Jang, Chang Heon Choi, Hyeongmin Jin, Jaeman Son, Jongmin Park, Jung-in Kim, Seonghee Kang, Sung Hyun Lee, Yoonsuk Huh. Progress in Medical Physics 2026;37:89-107. https://doi.org/10.14316/pmp.2026.37.3.89
- 30 September 2026
- Published by Korean Society of Medical Physics in Progress in Medical Physics
- Vol. 37 (3) , 89-107
Open AccessRisk-Based Management of Patients with Cardiac Implantable Electronic Devices Underwent Radiation Therapy: A Practical Review
Na Hye Kwon, Inbum Lee, Euntaek Yoon, Bo-Wi Cheon, Young Jae Jang, Chang Heon Choi, Hyeongmin Jin, Jaeman Son, Jongmin Park, Jung-in Kim, Seonghee Kang, Sung Hyun Lee, Yoonsuk Huh. Progress in Medical Physics 2026;37:89-107. https://doi.org/10.14316/pmp.2026.37.3.89
- Open Access
- 15 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0358184
Impact of dual-layer spectral CT-derived stopping power ratio on single-energy CT-based carbon-ion treatment planning for thoracic cancer
Purpose: To evaluate the impact of stopping-power ratio (SPR) predictions derived from dual-layer detector-based spectral CT (DLCT) on conventional single-energy CT (SECT)-based carbon-ion treatment planning for thoracic cancer. Methods: Twenty patients with thoracic cancer who underwent non-contrast DLCT were retrospectively included. DLCT-based SPR images were generated from effective atomic number and relative electron density maps using the Bethe equation. SECT-based SPR was derived using a Hounsfield unit look-up table generated via stoichiometric calibration of a commercial electron density phantom. Using the same phantom, a phantom-based prediction assessment was performed by comparing SECT- and DLCT-based SPR predictions with theoretical SPR values for the inserts. For patient analysis, normal-tissue SPR values derived from SECT and DLCT were compared. Carbon-ion treatment plans were first generated based on SECT images and then recalculated using DLCT-derived SPR images. Range differences in the beam’s-eye view and dose–volume histogram parameters for the planning target volume and organs at risk were evaluated. Results: In the phantom-based assessment, the root-mean-square error relative to the theoretical SPR was 5.57% for SECT and 2.83% for DLCT. In patient images, mean SPR differences between SECT and DLCT were 3.62% for the lungs, 1.93% for the esophagus, 0.04% for the heart, 0.93% for the spinal cord, and 1.53% for the ribs. Across the patient cohort, the mean recalculated range difference was 0.71 ± 0.89 mm, corresponding to a relative difference of 0.60 ± 0.67%. No statistically significant differences were observed in target dose metrics, whereas selected organ-at-risk metrics showed statistically significant differences between SECT-based plans and DLCT-based recalculations. Conclusion: DLCT-derived SPR prediction showed better agreement with theoretical phantom SPR values in the phantom-based prediction assessment and produced tissue-dependent SPR differences in thoracic patient images compared with conventional SECT-based prediction. Recalculation on DLCT-derived SPR maps resulted in modest but systematic range differences and limited changes in selected dose metrics. These results may inform the implementation and future independent validation of patient-specific DLCT-based SPR workflows in carbon-ion treatment planning for thoracic cancer.
- 15 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0358184
Open AccessImpact of dual-layer spectral CT-derived stopping power ratio on single-energy CT-based carbon-ion treatment planning for thoracic cancer
Purpose: To evaluate the impact of stopping-power ratio (SPR) predictions derived from dual-layer detector-based spectral CT (DLCT) on conventional single-energy CT (SECT)-based carbon-ion treatment planning for thoracic cancer. Methods: Twenty patients with thoracic cancer who underwent non-contrast DLCT were retrospectively included. DLCT-based SPR images were generated from effective atomic number and relative electron density maps using the Bethe equation. SECT-based SPR was derived using a Hounsfield unit look-up table generated via stoichiometric calibration of a commercial electron density phantom. Using the same phantom, a phantom-based prediction assessment was performed by comparing SECT- and DLCT-based SPR predictions with theoretical SPR values for the inserts. For patient analysis, normal-tissue SPR values derived from SECT and DLCT were compared. Carbon-ion treatment plans were first generated based on SECT images and then recalculated using DLCT-derived SPR images. Range differences in the beam’s-eye view and dose–volume histogram parameters for the planning target volume and organs at risk were evaluated. Results: In the phantom-based assessment, the root-mean-square error relative to the theoretical SPR was 5.57% for SECT and 2.83% for DLCT. In patient images, mean SPR differences between SECT and DLCT were 3.62% for the lungs, 1.93% for the esophagus, 0.04% for the heart, 0.93% for the spinal cord, and 1.53% for the ribs. Across the patient cohort, the mean recalculated range difference was 0.71 ± 0.89 mm, corresponding to a relative difference of 0.60 ± 0.67%. No statistically significant differences were observed in target dose metrics, whereas selected organ-at-risk metrics showed statistically significant differences between SECT-based plans and DLCT-based recalculations. Conclusion: DLCT-derived SPR prediction showed better agreement with theoretical phantom SPR values in the phantom-based prediction assessment and produced tissue-dependent SPR differences in thoracic patient images compared with conventional SECT-based prediction. Recalculation on DLCT-derived SPR maps resulted in modest but systematic range differences and limited changes in selected dose metrics. These results may inform the implementation and future independent validation of patient-specific DLCT-based SPR workflows in carbon-ion treatment planning for thoracic cancer.
- 29 July 2026
- Published by Elsevier in Physica Medica
- Vol. 148
Technical evaluation of a multipurpose phantom for selected CBCT QA endpoints across linac platforms
- 29 July 2026
- Published by Elsevier in Physica Medica
- Vol. 148
Technical evaluation of a multipurpose phantom for selected CBCT QA endpoints across linac platforms
- Open Access
- 22 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0354149
In vivo rectal dosimeter with MRI marker
Background: Hypofractionated external beam radiotherapy for prostate cancer necessitates precise rectal dose evaluation. We fabricated a radiochromic polyurethane-based in vivo rectal dosimeter with a custom MRI marker and a patient-specific applicator for in vivo dose verification (IDV) during gated MR-image guided radiotherapy (MR-IGRT). Methods: The dosimeter featured a radiochromic polyurethane active layer, incorporating leucomalachite green (LMG) and tartrazine. To accommodate anatomical variations, a detachable PMMA applicator was designed in five sizes. For localization, four elastomeric materials, including two polyurethane-based and two silicone-based materials, were evaluated as candidate MRI markers. Post-irradiation fading was assessed over time to evaluate measurement stability. A dose-response calibration was performed to establish a linear relationship between net optical density (OD) and absorbed dose. Furthermore, dose uncertainty was analyzed based on the law of error propagation. For verification, in vivo measurements were conducted for two patients and compared with TPS-calculated doses. Results: Vyta Flex 20 was selected as the optimal MRI marker due to its high signal intensity and ease of fabrication. Post-irradiation net OD showed a dose-dependent temporal response, and the readout time was standardized to 2 h. The dosimeter’s sensitivity was 0.00253 cGy -1 . Dose uncertainties were determined to be 2.1%, 2.0%, and 1.6% at 100, 200, and 300 cGy, respectively. In vivo verification showed mean dose differences of 3.7 ± 1.4% (95% CI, 0.1–7.3%) for patient #1 and 5.9 ± 2.1% (95% CI, 0.8–11.1%) for patient #2. Measured doses were consistently higher than TPS-calculated doses, suggesting possible contributions from localization uncertainty in high-dose-gradient regions and the material-dependent response of the radiochromic active layer. Conclusion: The fabricated radiochromic dosimeter with a custom MRI marker and adjustable applicator demonstrated preliminary feasibility as a proof-of-concept system for in vivo rectal dose verification during MR-IGRT. Further studies with larger patient cohorts and more treatment fractions are required to validate its reproducibility, statistical robustness, and clinical utility. Further refinement in positioning is also needed, particularly in dose-gradient regions.
- 22 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0354149
Open AccessIn vivo rectal dosimeter with MRI marker
Background: Hypofractionated external beam radiotherapy for prostate cancer necessitates precise rectal dose evaluation. We fabricated a radiochromic polyurethane-based in vivo rectal dosimeter with a custom MRI marker and a patient-specific applicator for in vivo dose verification (IDV) during gated MR-image guided radiotherapy (MR-IGRT). Methods: The dosimeter featured a radiochromic polyurethane active layer, incorporating leucomalachite green (LMG) and tartrazine. To accommodate anatomical variations, a detachable PMMA applicator was designed in five sizes. For localization, four elastomeric materials, including two polyurethane-based and two silicone-based materials, were evaluated as candidate MRI markers. Post-irradiation fading was assessed over time to evaluate measurement stability. A dose-response calibration was performed to establish a linear relationship between net optical density (OD) and absorbed dose. Furthermore, dose uncertainty was analyzed based on the law of error propagation. For verification, in vivo measurements were conducted for two patients and compared with TPS-calculated doses. Results: Vyta Flex 20 was selected as the optimal MRI marker due to its high signal intensity and ease of fabrication. Post-irradiation net OD showed a dose-dependent temporal response, and the readout time was standardized to 2 h. The dosimeter’s sensitivity was 0.00253 cGy -1 . Dose uncertainties were determined to be 2.1%, 2.0%, and 1.6% at 100, 200, and 300 cGy, respectively. In vivo verification showed mean dose differences of 3.7 ± 1.4% (95% CI, 0.1–7.3%) for patient #1 and 5.9 ± 2.1% (95% CI, 0.8–11.1%) for patient #2. Measured doses were consistently higher than TPS-calculated doses, suggesting possible contributions from localization uncertainty in high-dose-gradient regions and the material-dependent response of the radiochromic active layer. Conclusion: The fabricated radiochromic dosimeter with a custom MRI marker and adjustable applicator demonstrated preliminary feasibility as a proof-of-concept system for in vivo rectal dose verification during MR-IGRT. Further studies with larger patient cohorts and more treatment fractions are required to validate its reproducibility, statistical robustness, and clinical utility. Further refinement in positioning is also needed, particularly in dose-gradient regions.
- Open Access
- 9 April 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (9)
Microdosimetric kinetic model for enhanced estimation of cell survival in aerobic human salivary gland cells under heavy ion irradiation
Objective. Accurate estimation of cell survival fractions across a broad range of linear energy transfer (LET) is essential for precise heavy ion therapy planning. The microdosimetric kinetic (MK) model predicts cell survival from microdosimetric quantities; however, most closed-form MK formulations treat the quadratic coefficient β as a constant, which limits predictive accuracy under high-LET irradiation. This study aimed to develop a revised MK model that overcomes this limitation by redefining β as an LET-dependent function. Approach. The revised MK model incorporates the saturation-corrected dose-mean specific energy into the formulation of β. Model performance was evaluated against the reference MK model using 324 reconstructed survival fraction data points from 54 irradiation conditions of aerobic human salivary gland tumor cells exposed to helium, carbon, and neon ions. Parameter estimation was performed using a log-scaled mean squared error loss optimized through a hybrid global–local scheme. Main results. At low LET, both the revised and reference models reproduced experimental survival with comparable accuracy. However, at higher LET, the revised model maintained stable agreement with experimental data, whereas the reference model diverged markedly due to excessive curvature in its predictions. Across the entire experimental LET range, the revised model consistently reproduced cell survival data more accurately than the reference model. Significance. These findings demonstrate that redefining the quadratic coefficient as an LET-dependent term substantially improves the predictive accuracy of the MK model under high-LET and wide-dose conditions. The proposed model enhances radiobiological modeling performance while preserving the structural simplicity and compatibility of the existing MK framework.
- 9 April 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (9)
Open AccessMicrodosimetric kinetic model for enhanced estimation of cell survival in aerobic human salivary gland cells under heavy ion irradiation
Objective. Accurate estimation of cell survival fractions across a broad range of linear energy transfer (LET) is essential for precise heavy ion therapy planning. The microdosimetric kinetic (MK) model predicts cell survival from microdosimetric quantities; however, most closed-form MK formulations treat the quadratic coefficient β as a constant, which limits predictive accuracy under high-LET irradiation. This study aimed to develop a revised MK model that overcomes this limitation by redefining β as an LET-dependent function. Approach. The revised MK model incorporates the saturation-corrected dose-mean specific energy into the formulation of β. Model performance was evaluated against the reference MK model using 324 reconstructed survival fraction data points from 54 irradiation conditions of aerobic human salivary gland tumor cells exposed to helium, carbon, and neon ions. Parameter estimation was performed using a log-scaled mean squared error loss optimized through a hybrid global–local scheme. Main results. At low LET, both the revised and reference models reproduced experimental survival with comparable accuracy. However, at higher LET, the revised model maintained stable agreement with experimental data, whereas the reference model diverged markedly due to excessive curvature in its predictions. Across the entire experimental LET range, the revised model consistently reproduced cell survival data more accurately than the reference model. Significance. These findings demonstrate that redefining the quadratic coefficient as an LET-dependent term substantially improves the predictive accuracy of the MK model under high-LET and wide-dose conditions. The proposed model enhances radiobiological modeling performance while preserving the structural simplicity and compatibility of the existing MK framework.
- Open Access
- 31 December 2025
- Published by Korean Society of Medical Physics in Progress in Medical Physics
- Vol. 36 (4) , 100-107
Validation of Clinically Optimized Multi-Leaf Collimator Parameters Using Enhanced Leaf Modeling in the AcurosXB Algorithm
Jin Jegal, Yoonsuk Huh, Inbum Lee, Bo-Wi Cheon, Euntaek Yoon, Chang Heon Choi, Jung-in Kim, Seonghee Kang. Progress in Medical Physics 2025;36:100-7. https://doi.org/10.14316/pmp.2025.36.4.100
- 31 December 2025
- Published by Korean Society of Medical Physics in Progress in Medical Physics
- Vol. 36 (4) , 100-107
Open AccessValidation of Clinically Optimized Multi-Leaf Collimator Parameters Using Enhanced Leaf Modeling in the AcurosXB Algorithm
Jin Jegal, Yoonsuk Huh, Inbum Lee, Bo-Wi Cheon, Euntaek Yoon, Chang Heon Choi, Jung-in Kim, Seonghee Kang. Progress in Medical Physics 2025;36:100-7. https://doi.org/10.14316/pmp.2025.36.4.100
- Open Access
- 31 December 2025
- Published by Korean Society of Medical Physics in Progress in Medical Physics
- Vol. 36 (4) , 165-174
Performance Evaluation of the HyperSight Cone-Beam Computed Tomography System on the Halcyon Platform: Installation Acceptance and Quantitative Image Quality Assessment
Yoonsuk Huh, Euntaek Yoon, Jin Jegal, Inbum Lee, Bo-Wi Cheon, Jongmin Park, Jung-in Kim, Chang Heon Choi, Seonghee Kang, Sung Hyun Lee, Hyeongmin Jin, Jaeman Son. Progress in Medical Physics 2025;36:165-74. https://doi.org/10.14316/pmp.2025.36.4.165
- 31 December 2025
- Published by Korean Society of Medical Physics in Progress in Medical Physics
- Vol. 36 (4) , 165-174
Open AccessPerformance Evaluation of the HyperSight Cone-Beam Computed Tomography System on the Halcyon Platform: Installation Acceptance and Quantitative Image Quality Assessment
Yoonsuk Huh, Euntaek Yoon, Jin Jegal, Inbum Lee, Bo-Wi Cheon, Jongmin Park, Jung-in Kim, Chang Heon Choi, Seonghee Kang, Sung Hyun Lee, Hyeongmin Jin, Jaeman Son. Progress in Medical Physics 2025;36:165-74. https://doi.org/10.14316/pmp.2025.36.4.165
- Open Access
- 31 December 2025
- Published by Korean Society of Medical Physics in Progress in Medical Physics
- Vol. 36 (4) , 139-146
Clinical Validation of EPIbeam as a Patient-Specific Pre-Treatment Quality Assurance System
Euntaek Yoon, Inbum Lee, Yoonsuk Huh, Bo-Wi Cheon, Jin Jegal, Hyeongmin Jin, Sung Hyun Lee, Seonghee Kang, Chang Heon Choi, Jong Min Park, Jung-in Kim, Jaeman Son. Progress in Medical Physics 2025;36:139-46. https://doi.org/10.14316/pmp.2025.36.4.139
- 31 December 2025
- Published by Korean Society of Medical Physics in Progress in Medical Physics
- Vol. 36 (4) , 139-146
Open AccessClinical Validation of EPIbeam as a Patient-Specific Pre-Treatment Quality Assurance System
Euntaek Yoon, Inbum Lee, Yoonsuk Huh, Bo-Wi Cheon, Jin Jegal, Hyeongmin Jin, Sung Hyun Lee, Seonghee Kang, Chang Heon Choi, Jong Min Park, Jung-in Kim, Jaeman Son. Progress in Medical Physics 2025;36:139-46. https://doi.org/10.14316/pmp.2025.36.4.139
- Open Access
- 31 December 2025
- Published by Korean Society of Medical Physics in Progress in Medical Physics
- Vol. 36 (4) , 147-154
Head Leakage in Modern Clinical Linear Accelerators: A Multimachine Appraisal at Seoul National University Hospital
Inbum Lee, Euntaek Yoon, Bo-Wi Cheon, Jin Jegal, Yoonsuk Huh, Jong Min Park, Jung-in Kim, Chang Heon Choi, Seonghee Kang, Jaeman Son, Hyeongmin Jin, Sung Hyun Lee. Progress in Medical Physics 2025;36:147-54. https://doi.org/10.14316/pmp.2025.36.4.147
- 31 December 2025
- Published by Korean Society of Medical Physics in Progress in Medical Physics
- Vol. 36 (4) , 147-154
Open AccessHead Leakage in Modern Clinical Linear Accelerators: A Multimachine Appraisal at Seoul National University Hospital
Inbum Lee, Euntaek Yoon, Bo-Wi Cheon, Jin Jegal, Yoonsuk Huh, Jong Min Park, Jung-in Kim, Chang Heon Choi, Seonghee Kang, Jaeman Son, Hyeongmin Jin, Sung Hyun Lee. Progress in Medical Physics 2025;36:147-54. https://doi.org/10.14316/pmp.2025.36.4.147